HK16090A - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
HK16090A
HK16090A HK160/90A HK16090A HK16090A HK 16090 A HK16090 A HK 16090A HK 160/90 A HK160/90 A HK 160/90A HK 16090 A HK16090 A HK 16090A HK 16090 A HK16090 A HK 16090A
Authority
HK
Hong Kong
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
HK160/90A
Other languages
English (en)
Inventor
Robert Charles Hider
George Kontoghiorghes
Michael Arthur Stockham
Original Assignee
Nat Res Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA000524044A external-priority patent/CA1338496C/en
Application filed by Nat Res Dev filed Critical Nat Res Dev
Publication of HK16090A publication Critical patent/HK16090A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C07D309/40—Oxygen atoms attached in positions 3 and 4, e.g. maltol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
HK160/90A 1982-10-22 1990-03-01 Pharmaceutical compositions HK16090A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB8230150 1982-10-22
CA000446932A CA1243606A (en) 1982-10-22 1984-02-07 Pharmaceutical compositions containing iron complexes of 3-hydroxy-4-pyrones
CA000524044A CA1338496C (en) 1982-10-22 1986-11-28 Pharmaceutically active iron complexes of 3-hydroxy-4-pyrones

Publications (1)

Publication Number Publication Date
HK16090A true HK16090A (en) 1990-03-09

Family

ID=27167414

Family Applications (1)

Application Number Title Priority Date Filing Date
HK160/90A HK16090A (en) 1982-10-22 1990-03-01 Pharmaceutical compositions

Country Status (8)

Country Link
US (3) US4575502A (xx)
EP (1) EP0107458B1 (xx)
JP (2) JPS5993071A (xx)
AU (1) AU567915B2 (xx)
CA (1) CA1243606A (xx)
DK (1) DK485383D0 (xx)
GB (1) GB2128998B (xx)
HK (1) HK16090A (xx)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0107458B1 (en) * 1982-10-22 1987-07-29 National Research Development Corporation Pharmaceutical compositions
USRE37534E1 (en) 1982-10-22 2002-01-29 Btg International Limited Pharmaceutical compositions
US4708862A (en) * 1983-02-22 1987-11-24 Xoma Corporation Radioimmuno detection of human cancers using anti-tumor monoclonal antibody
US4912118A (en) * 1983-09-23 1990-03-27 National Research Development Corporation Pharmaceutical compositions
GB8329043D0 (en) * 1983-10-31 1983-11-30 Hider R C Pharmaceutical compositions
GB8410290D0 (en) * 1984-04-19 1984-05-31 Callingham B A Pharmaceutical compositions
GB8410289D0 (en) * 1984-04-19 1984-05-31 Callingham B A Pharmaceutical compositions
US5177068A (en) * 1984-04-19 1993-01-05 National Research Development Corporation Pharmaceutical compositions
GB8615041D0 (en) * 1986-06-20 1986-07-23 Silver J Pharmaceutical compositions
US5258376A (en) * 1989-11-22 1993-11-02 Bernstein Lawrence R Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones
US5574027A (en) * 1989-11-22 1996-11-12 Bernstein; Lawrence R. Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones
US6004951A (en) * 1989-11-22 1999-12-21 Bernstein; Lawrence Richard Administration of gallium complexes of 3-hydroxy-4-pyrones to provide physiologically active gallium levels in a mammalian individual
GB9006522D0 (en) * 1990-03-23 1990-05-23 Hider Robert C Metal complexes
WO1991017751A1 (en) * 1990-05-24 1991-11-28 Fujisawa, Inc. Orally administrable gallium compositions and methods of treatment therewith
US5298525A (en) * 1992-11-23 1994-03-29 University Technologies International, Inc. Diabetes prevention and treatment
EP0833627B1 (en) 1995-06-10 2004-08-18 Vitra Pharmaceuticals Ltd. Iron compounds, compositions, methods of making the same and uses thereof
US5906978A (en) * 1996-08-14 1999-05-25 Hemocleanse, Inc. Method for iron delivery to a patient by transfer from dialysate
GB9621273D0 (en) 1996-10-11 1996-11-27 Cortecs Ltd Therapeutic method
PL194985B1 (pl) * 1998-09-23 2007-07-31 Unilever Nv Kompozycja do pielęgnacji jamy ustnej oraz zastosowanie kompleksów dwuwartościowej miedzi, cynku, żelaza lub cyny albo trójwartościowego żelaza
PT1072198E (pt) * 1999-07-28 2008-06-17 Swiss Caps Rechte & Lizenzen Preparado, especialmente para utilização como medicamento e/ou como suplemento alimentar
US6767741B1 (en) * 1999-08-27 2004-07-27 Invitrogen Corporation Metal binding compounds and their use in cell culture medium compositions
DE60107272T2 (de) 2000-09-19 2005-10-27 Vitra Pharmaceuticals Ltd., Saffron Walden Eisenverbindungen
US7073271B2 (en) * 2002-02-14 2006-07-11 Faro Technologies Inc. Portable coordinate measurement machine
RU2209062C1 (ru) * 2002-03-19 2003-07-27 Институт физиологии им. И.П.Павлова РАН Вещество, обладающее седативным действием
GB0211500D0 (en) 2002-05-18 2002-06-26 Vitra Pharmaceuticals Ltd Method of forming iron hydroxypyrone compounds
AU2005284909B2 (en) * 2004-09-13 2011-11-17 Gilead Sciences, Inc. Delivering iron to an animal
BRPI0515847A (pt) * 2004-10-08 2008-08-12 Unilever Nv uso de um complexo de ferro, composição alimentìcia, gênero alimentìcio fortificado com ferro, composição de bebida, bebida fortificada com ferro, suplemento alimentar e composição farmacêutica
US7857977B2 (en) * 2005-07-12 2010-12-28 Rockwell Medical Technologies, Inc. Packaging of ferric pyrophosphate for dialysis
US7816404B2 (en) 2007-07-20 2010-10-19 Rockwell Medical Technologies, Inc. Methods for the preparation and use of ferric pyrophosphate citrate chelate compositions
GB0808835D0 (en) 2008-05-15 2008-06-18 Vitra Pharmaceuticals Ltd Therapeutic compositions
AR077101A1 (es) 2009-06-16 2011-08-03 Schering Corp Esteroides de heteroarilo (3,2-c), como agonistas de receptor glucocorticoide, composiciones y usos de los mismos
RU2589710C2 (ru) 2010-03-23 2016-07-10 Вифор (Интернациональ) Аг Комплексные соединения железа(iii) для лечения и профилактики симптомов железодефицита и железодефицитной анемии
GB201101370D0 (en) * 2011-01-27 2011-03-09 Iron Therapeutics Holdings Ag Process
US9422247B2 (en) 2011-03-29 2016-08-23 Vifor (International) Ag Fe(III) complex compounds for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anemias
ES2548407T3 (es) 2011-05-31 2015-10-16 Vifor (International) Ag Compuestos de complejos de 2,4-dioxo-1-carbonilo de Fe(III) para su uso en el tratamiento y la profilaxis de estados de deficiencia de hierro y anemias por deficiencia de hierro
RU2641030C2 (ru) 2012-12-21 2018-01-15 Вифор (Интернациональ) Аг Комплексные соединения трехвалентного железа для лечения и профилактики симптомов дефицита железа и железодефицитных анемий
GB201404390D0 (en) * 2014-03-12 2014-04-23 Iron Therapeutics Holdings Ag Composition
GB2531742B (en) * 2014-10-28 2016-10-05 Iron Therapeutics Holdings Ag Polymorphs of ferric maltol
IT202100018578A1 (it) * 2021-07-14 2023-01-14 Indena Spa Dispersione amorfa di maltolo ferrico e relativo processo di preparazione
US11661819B2 (en) 2021-08-03 2023-05-30 Baker Hughes Oilfield Operations Llc Valve, method and system

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2904573A (en) * 1957-05-06 1959-09-15 Ortho Pharma Corp Ferrous citrate complex
US2865938A (en) * 1957-09-25 1958-12-23 Hyman Rosenstein Iron choline compound and production thereof
US3130204A (en) * 1962-02-07 1964-04-21 Pfizer & Co C Preparation of gamma-pyrones
FR2130M (fr) * 1962-04-25 1963-11-12 Rech S Appliquees Soc D Expl Médicament a base d'une solution aqueuse stable de chlorure ferreux et d'acide ascorbique.
DE1518098A1 (de) * 1963-09-19 1969-04-10 Pfizer & Co C Verfahren zur Herstellung von Pyromekonsaeurederivaten
US3821192A (en) * 1971-08-18 1974-06-28 Central Pharmacal Co Process for preparing an iron-saccharide complex
US4018937A (en) * 1972-12-14 1977-04-19 Rca Corporation Electron beam recording comprising polymer of 1-methylvinyl methyl ketone
US4058621A (en) * 1975-02-24 1977-11-15 Peter, Strong & Company, Inc. Iron complexes and foodstuffs containing them
DE2613500A1 (de) * 1975-04-01 1976-10-21 Procter & Gamble Mundpflegemittel und verfahren zur verhinderung von verfaerbungen der zaehne
US4018907A (en) * 1975-08-25 1977-04-19 General Foods Corporation Coloring food with iron-complexes
US4018934A (en) * 1975-08-25 1977-04-19 General Foods Corporation Stabilization of iron - complex colors
US4311691A (en) * 1979-10-09 1982-01-19 Fichera Anthony T Tobacco smoking inhibitor
EP0107458B1 (en) * 1982-10-22 1987-07-29 National Research Development Corporation Pharmaceutical compositions

Also Published As

Publication number Publication date
AU2455284A (en) 1985-08-15
GB2128998A (en) 1984-05-10
US4834983A (en) 1989-05-30
JPH03223274A (ja) 1991-10-02
EP0107458B1 (en) 1987-07-29
JPS5993071A (ja) 1984-05-29
AU567915B2 (en) 1987-12-10
JPH0336807B1 (xx) 1991-06-03
CA1243606A (en) 1988-10-25
US4861767A (en) 1989-08-29
EP0107458A1 (en) 1984-05-02
JPH0545589B2 (xx) 1993-07-09
GB8327612D0 (en) 1983-11-16
US4575502A (en) 1986-03-11
DK485383D0 (da) 1983-10-21
GB2128998B (en) 1986-07-16

Similar Documents

Publication Publication Date Title
GB8326565D0 (en) Pharmaceutical compositions
HK16090A (en) Pharmaceutical compositions
GB2136807B (en) Pharmaceutical compositions
DE3467703D1 (en) Pharmaceutical compositions
CY1678A (en) Pharmaceutical compositions
ZA834074B (en) Pharmaceutical composition
GB2136806B (en) Pharmaceutical compositions
ZA833781B (en) Pharmaceutical compositions
EP0093551A3 (en) Pharmaceutical composition
CY1503A (en) Pharmaceutical compositions
GB2118176B (en) Pharmaceutical compositions
GB2117766B (en) Pharmaceutical compositions
PT77323A (en) Pharmaceutical compositions
GB8429749D0 (en) Pharmaceutical compositions
GB8313814D0 (en) Pharmaceutical compositions
GB8329700D0 (en) Anti-haemophilic pharmaceutical composition
DE3377696D1 (en) Pharmaceutical compositions
US4594359B1 (en) Pharmaceutical compositions
GB8328896D0 (en) Pharmaceutical composition
EP0136006A3 (en) Pharmaceutical compositions
GB2114001B (en) Nasel pharmaceutical compositions
GB8305028D0 (en) Pharmaceutical compositions
GB8314736D0 (en) Pharmaceutical compositions
GB8330810D0 (en) Pharmaceutical compositions
GB8332653D0 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)